HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qingman Luo Selected Research

phillyrin

7/2022Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qingman Luo Research Topics

Disease

1Diabetic Nephropathies (Diabetic Nephropathy)
07/2022
1Cardiomegaly (Heart Hypertrophy)
07/2022
1Hypertrophy
07/2022

Drug/Important Bio-Agent (IBA)

1phillyrinIBA
07/2022
1AntioxidantsIBA
07/2022
1CatecholaminesIBA
07/2022
1Atrial Natriuretic Factor (ANF)IBA
07/2022
1Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2022
1NF-kappa B (NF-kB)IBA
07/2022
1p38 Mitogen-Activated Protein KinasesIBA
07/2022

Therapy/Procedure

1Subcutaneous Injections
07/2022